On the recordNovember 14, 2011
I'm concerned that duplicative regulation could slow innovation, impeding improvements to patient care as well as the job growth.
Source
congress.govEditor's note · Context
Hagan expresses concern about FDA's proposed regulation affecting innovation and job growth.
Share & report
More from Kay Hagan
Jul 10, 2014
Mr. President, I ask unanimous consent that the Committee on Finance be authorized to meet during the session of the Senate on July 10, 2013, at 2:30 p.m., in room SD-215 of the Dirksen Senate Office Building, to conduct a hearing entitled…
Jul 7, 2014
Certainly. Obviously, we're talking about those situations where the stories that we've heard this morning and have read about are on the other end of that spectrum.
Jul 15, 2014
Mr. President, I would like to ask for another 45 seconds. The PRESIDING OFFICER. Hearing no objection, it is so ordered.
Other voices in this conversation
